According to the FDA, the shift is one of many steps in the agency’s broader data modernization strategy to streamline all of its adverse event reporting systems and increase reporting frequency across all systems to identify safety signals faster.
Blinking decreases and eye strain increases during one hour of smartphone use, with dynamic screen changes from social media reels creating the highest visual load.
Eyenovia's late-stage study for near-sightedness in children with an experimental drug-device combination has been discontinued after failing to slow myopia progression, leading to consideration of strategic alternatives.